Paragon Advisors’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-9,315
| Closed | -$1.39M | – | 85 |
|
2021
Q4 | $1.39M | Sell |
9,315
-5,669
| -38% | -$845K | 0.68% | 40 |
|
2021
Q3 | $2.18M | Buy |
14,984
+2,813
| +23% | +$409K | 1.06% | 30 |
|
2021
Q2 | $2.38M | Buy |
12,171
+4,200
| +53% | +$822K | 1.12% | 26 |
|
2021
Q1 | $1.44M | Buy |
7,971
+800
| +11% | +$145K | 0.79% | 31 |
|
2020
Q4 | $1.01M | Sell |
7,171
-85
| -1% | -$11.9K | 0.54% | 53 |
|
2020
Q3 | $905K | Buy |
7,256
+895
| +14% | +$112K | 0.6% | 51 |
|
2020
Q2 | $568K | Buy |
+6,361
| New | +$568K | 0.46% | 71 |
|